IDEAYA Biosciences (IDYA) Revenue Growth (3y) (2023 - 2026)
IDEAYA Biosciences (IDYA) Revenue Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,538.84 Bn | 65,538.56 Bn | - | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 469.46 Bn | 464.67 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 122.69 Bn | 115.45 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 70.41 Bn | 61.65 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 62.84 Bn | 62.84 Bn | - | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn | 79.44% |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn | 54.05% |
| 10 | IDEAYA Biosciences | 3.22 Bn | 2.54 Bn | - | -5.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.93% |
| Dec 31, 2025 | 39.32% |
| Sep 30, 2025 | 91.28% |
| Dec 31, 2024 | 33.20% |
| Dec 31, 2023 | -28.14% |
| Sep 30, 2023 | -3.58% |